You are here

  • Home
  • Archive
  • Volume 14, Issue 2
  • Seroprevalence of Japanese encephalitis virus-specific antibodies in Australia following novel epidemic spread: protocol for a national cross-sectional study

Article info

Article menu

This article has a correction. Please see:

Infectious diseases
Protocol
Seroprevalence of Japanese encephalitis virus-specific antibodies in Australia following novel epidemic spread: protocol for a national cross-sectional study

Authors

  • Noni Ella Winkler National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Westmead, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Archana Koirala National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Westmead, New South Wales, Australia Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Guddu Kaur National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Westmead, New South Wales, Australia National Centre for Epidemiology and Population Health, Australian National University, Canberra, Australian Capital Territory, Australia PubMed articlesGoogle scholar articles
  • Shayal Prasad National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Westmead, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Rena Hirani Australian Red Cross Lifeblood, Sydney, New South Wales, Australia Faculty of Science and Engineering, Macquarie University, Macquarie Park, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Jannah Baker The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Veronica Hoad Australian Red Cross Lifeblood, Perth, Western Australia, Australia PubMed articlesGoogle scholar articles
  • Iain B Gosbell Australian Red Cross Lifeblood, Sydney, New South Wales, Australia School of Medicine, Western Sydney University, Penrith South DC, New South Wales, Australia PubMed articlesGoogle scholar articles
  • David O Irving Australian Red Cross Lifeblood, Sydney, New South Wales, Australia Faculty of Health, University of Technology Sydney, Broadway, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Linda Hueston New South Wales Health Pathology - Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, New South Wales, Australia Griffith University Menzies Health Institute Queensland, Brisbane, Queensland, Australia PubMed articlesGoogle scholar articles
  • Matthew VN O'Sullivan Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia New South Wales Health Pathology - Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Jen Kok New South Wales Health Pathology - Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Dominic E Dwyer Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia New South Wales Health Pathology - Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Kristine Macartney National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, Westmead, New South Wales, Australia Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia PubMed articlesGoogle scholar articles
  • on behalf of the Australian Japanese Encephalitis Virus Serosurvey Group
    Google scholar articles
  1. Correspondence to Dr Archana Koirala; archana.koirala{at}health.nsw.gov.au
View Full Text

Citation

Winkler NE, Koirala A, Kaur G, et al
Seroprevalence of Japanese encephalitis virus-specific antibodies in Australia following novel epidemic spread: protocol for a national cross-sectional study
BMJ Open 2024;14:e075569. doi: 10.1136/bmjopen-2023-075569

Publication history

  • Received May 12, 2023
  • Accepted November 8, 2023
  • First published February 7, 2024.
Online issue publication 
February 07, 2024
Previous versions
Review history

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.